Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-17 Sale |
2023-01-19 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,442 | $312.04 | $1,386,099 | 33,433 (Direct) |
View |
| 2022-11-15 Sale |
2022-11-17 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
34 | $308.61 | $10,493 | 36,077 (Direct) |
View |
| 2022-11-07 Sale |
2022-11-09 4:40 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,303 | $303.04 | $394,859 | 37,381 (Direct) |
View |
| 2022-11-02 Sale |
2022-11-03 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
320 | $312.64 | $100,045 | 38,104 (Direct) |
View |
| 2022-10-24 Sale |
2022-10-26 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
621 | $310 | $192,510 | 4,040 (Direct) |
View |
| 2022-10-18 Sale |
2022-10-20 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,791 | $300.31 | $537,860 | 39,192 (Direct) |
View |
| 2022-08-15 Sale |
2022-08-17 5:40 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
11,689 | $305.06 | $3,565,846 | 99,598 (Direct) |
View |
| 2022-08-15 Sale |
2022-08-17 5:39 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
22,173 | $303.93 | $6,738,991 | 45,418 (Indirect Direct) |
View |
| 2022-08-15 Sale |
2022-08-17 5:36 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
3,747 | $303.9 | $1,138,723 | 9,605 (Direct) |
View |
| 2022-08-10 Sale |
2022-08-12 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
180 | $300.4 | $54,073 | 67,591 (Indirect Direct) |
View |
| 2022-08-10 Sale |
2022-08-12 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
36 | $300.32 | $10,812 | 13,352 (Direct) |
View |
| 2022-08-08 Sale |
2022-08-10 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
621 | $293.03 | $181,972 | 4,661 (Direct) |
View |
| 2022-08-09 Sale |
2022-08-10 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
946 | $300 | $283,800 | 13,388 (Direct) |
View |
| 2022-08-09 Sale |
2022-08-10 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
1,400 | $298.97 | $418,557 | 46,090 (Direct) |
View |
| 2022-08-09 Sale |
2022-08-10 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
5,690 | $300.67 | $1,710,817 | 67,771 (Indirect Direct) |
View |
| 2022-08-08 Sale |
2022-08-10 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $292.54 | $381,469 | 38,684 (Direct) |
View |
| 2022-07-29 Sale |
2022-08-02 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
621 | $278.77 | $173,116 | 5,282 (Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
132,079 | $281.38 | $37,164,481 | 36,387 (Indirect Direct) |
View |
| 2022-07-19 Sale |
2022-07-21 4:48 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
17,865 | $288.65 | $5,156,730 | 39,988 (Direct) |
View |
| 2022-06-24 Sale |
2022-06-28 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
11,689 | $291.3 | $3,405,006 | 111,153 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-18 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
45 | $252.83 | $11,377 | 41,749 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-18 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
133 | $251.19 | $33,408 | 64,900 (Indirect Direct) |
View |
| 2022-05-16 Sale |
2022-05-18 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
133 | $252.88 | $33,633 | 14,334 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-17 Exercise |
2023-01-19 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,442 | $72.14 | 33,433 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 4:07 pm |
N/A 2024-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,442 | $0 | 33,433 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
96 | $298.42 | 235 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
147 | $298.42 | 14,269 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
101 | $298.42 | 3,027 (Direct) |
View |
| 2022-12-06 Option Award |
2022-12-08 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
12,753 | $0 | 58,171 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 4:40 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,303 | $0 | 37,381 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 4:40 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,303 | $187.53 | 37,381 (Direct) |
View |
| 2022-11-01 Tax Withholding |
2022-11-03 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
768 | $312.84 | 38,104 (Direct) |
View |
| 2022-10-14 Option Award |
2022-10-18 4:30 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
97 | $296.82 | 139 (Direct) |
View |
| 2022-10-14 Option Award |
2022-10-18 4:27 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
147 | $296.82 | 14,122 (Direct) |
View |
| 2022-10-14 Option Award |
2022-10-18 4:25 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
101 | $296.82 | 2,927 (Direct) |
View |
| 2022-09-19 Option Award |
2022-09-21 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
5,294 | $0 | 5,294 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 5:39 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
6,571 | $155.57 | 45,418 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 5:39 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
6,571 | $0 | 45,418 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-12 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
64 | $155.57 | 67,591 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-12 4:05 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
64 | $0 | 67,591 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-10 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
1,926 | $155.57 | 67,771 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-10 4:06 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
1,926 | $0 | 67,771 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-10 4:06 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $0 | 38,684 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-10 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $187.53 | 38,684 (Direct) |
View |
| 2022-08-01 Tax Withholding |
2022-08-03 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
766 | $276.62 | 40,983 (Direct) |
View |
| 2022-07-25 Exercise |
2022-07-27 4:17 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
60,342 | $0 | 36,387 (Direct) |
View |
| 2022-07-25 Exercise |
2022-07-27 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
60,342 | $91.05 | 36,387 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
7,338 | $155.57 | 39,988 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 4:48 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
17,765 | $0 | 39,988 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
10,427 | $187.53 | 39,988 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:35 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
151 | $289.23 | 13,975 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:33 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
95 | $289.23 | 2,826 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:32 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
42 | $289.23 | 42 (Direct) |
View |
| 2022-05-31 Tax Withholding |
2022-06-02 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
311 | $271.24 | 49,512 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-19 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
1,558 | $0 | 1,558 (Direct) |
View |